Discovery of (2S,4R)-1-(2-aminoacetyl)-4-benzamidopyrrolidine-2-carboxylic acid hydrochloride (GAP-134)13, an orally active small molecule gap-junction modifier for the treatment of atrial fibrillation.

Source:http://linkedlifedata.com/resource/pubmed/id/19175320

J. Med. Chem. 2009 Feb 26 52 4 908-11

Download in:

View as

Triples

General Info

PMID
19175320